BCB Bancorp | 10-Q: FY2025 Q3 Revenue: USD 45.79 M

Revenue: As of FY2025 Q3, the actual value is USD 45.79 M.

EPS: As of FY2025 Q3, the actual value is USD 0.22, beating the estimate of USD 0.2133.

EBIT: As of FY2025 Q3, the actual value is USD -17.91 M.

Loans Receivable: $2,879,810 thousand for the three months ended September 30, 2025, compared to $3,159,574 thousand for the same period in 2024.
Investment Securities: $134,419 thousand for the three months ended September 30, 2025, compared to $96,893 thousand for the same period in 2024.
FHLB Stock and Other Interest Earnings-Assets: $250,869 thousand for the three months ended September 30, 2025, compared to $322,154 thousand for the same period in 2024.

Net Interest Income: $23,711 thousand for the three months ended September 30, 2025, compared to $23,045 thousand for the same period in 2024.
Provision for Credit Losses: $4,080 thousand for the three months ended September 30, 2025, compared to $2,890 thousand for the same period in 2024.
Net Income: $4,262 thousand for the three months ended September 30, 2025, compared to $6,668 thousand for the same period in 2024.
Non-Interest Income: $2,745 thousand for the three months ended September 30, 2025, compared to $3,127 thousand for the same period in 2024.
Non-Interest Expense: $16,570 thousand for the three months ended September 30, 2025, compared to $13,929 thousand for the same period in 2024.

Net Cash Provided by Operating Activities: $24,077 thousand for the nine months ended September 30, 2025, compared to $59,941 thousand for the same period in 2024.
Net Cash Provided by (Used In) Investing Activities: $154,763 thousand for the nine months ended September 30, 2025, compared to $139,292 thousand for the same period in 2024.
Net Cash (Used in) Provided by Financing Activities: -$246,508 thousand for the nine months ended September 30, 2025, compared to -$235,633 thousand for the same period in 2024.

Cannabis Related Loans: $69.1 million at September 30, 2025, compared to $103.2 million at December 31, 2024.
Non-Accrual Loans: $93.5 million at September 30, 2025, compared to $44.7 million at December 31, 2024.

Loan Portfolio Management: The company is focusing on managing its loan portfolio, particularly in the cannabis sector, which poses increased credit risk. The company has taken steps to address specific reserves tied to this sector.
Deposit Growth: The company aims to attract and deploy deposits effectively to support its lending and investment activities.

Reduction of Wholesale Funding: The company has reduced its exposure to wholesale funding by paying down high-cost brokered deposits and FHLB advances.
Investment in Securities: The company has increased its investment in securities, with a focus on maintaining a balanced portfolio.

Credit Quality Improvement: The company is prioritizing the improvement of credit quality, particularly in the cannabis loan portfolio, and is prepared to make material reserves if operating headwinds persist.
Operational Efficiency: The company is focusing on reducing non-interest expenses and improving operational efficiency to enhance profitability.